Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003389652 | SCV000698316 | likely benign | not specified | 2023-10-09 | criteria provided, single submitter | clinical testing | Variant summary: BMPR1A c.430+10C>T alters a non-conserved nucleotide located at a position not widely known to affect splicing. The variant was absent in 251416 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.430+10C>T has been reported in the literature. This report does not provide unequivocal conclusions about association of the variant with Juvenile Polyposis Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 28135145). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified as likely benign (n=1) and VUS (n=2). Based on the evidence outlined above, the variant was classified as likely benign. |
Invitae | RCV001410443 | SCV001612490 | likely benign | Juvenile polyposis syndrome | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255468 | SCV002528601 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-09-20 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000589857 | SCV002774451 | uncertain significance | not provided | 2021-09-05 | criteria provided, single submitter | clinical testing |